3Nikkels AF, Snoeck R, Rentier B, et al. Chronic verrueous varieella zoster virus skin lesions: clinical, histological, molecular and therapeutic aspects[J]. Clin Exp Dermatol, 1999, 24(5) : 346-353.
4Koyano S, Suzutani T, Yoshida I, et al. Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virusspecific enzymes[J]. Antimicrob Agents Chemother, 1996, 40(4): 920-923.
5Markham A, Faulds D. Ganciclovir. An update of its therapeutic use in cytomegalovirus infection[J]. Drugs, 1994, 48 (3) : 455-484.
6Snoeck R, Andrei G, De Clercq E. Current pharmacological approaches to the therapy of varicel/a zoster virus infections : a guide to treatment[J]. Drugs, 1999, 57(2): 187-206.
7Stranska R, Schuurman R, Nienhuis E, et al. Survey of acyclovirresistant herpes simplex virus in the Netherlands: prevalence and characterization[J]. J Clin Virol, 2005, 32( 1 ) : 7-18.
8楼之岑.中药志(第二册)[M].北京:人民卫生出版社,1982.448.
9Nikkels A F, Snoeck R, Rentier B, et al. Chronic verrucons varicella zoster virus skin lesions: clinical, histological, molecular and therapeutic aspects[J]. Clin Exp Dermatol, 1999, 24(5) : 346.
10Snoeck R, Andrei G, De Clercq E. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment[J]. Drugs, 1999, 2(57) : 187.
